Nanion Corporate Blog


12.05.2017: New Application Note on TREK-1 is out!


The latest Application Note from Nanion shows recordings of TREK-1 on the SyncroPatch 384PE.


HEK cells expressing TREK-1 (an excellent cell line from SB Drug Discovery) were used on the SyncroPatch 384PE with a high success rate and BL-1249 and THA were used to activate and inhibit TREK-1, respectively. Read the full allpication note here.


Back to Overview

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.